Herpes medication does not reduce risk of HIV infection in individuals with HSV-2

An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news121529697.html">Herpes medication does not reduce risk of HIV infection in individuals with HSV-2</a></p> <p>An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV.</p>